Multiple Sclerosis Clinical Trials in San Antonio

Showing 381-400 of 513 trials

Reliability of Dosing With NovoLog® Mix 70/30 FlexPen® Compared With Vial and Syringe

NCT00127296

This trial is conducted in the United States of America (USA). The aim of this trial is to compare desired (target) with actual target amounts of insulin dispensed using NovoLog® Mix 70/30 FlexPen® and vial and syringe in subjects with type 2 diabetes mellitus. No insulin is administered in this trial - insulin is dispensed into an empty vial.

DiabetesDiabetes Mellitus, Type 2Delivery Systems

Novo Nordisk A/S60 participantsStarted Jul 2005

San Antonio, Texas, United States

TERMINATEDPhase 2< 1 mile

Efficacy and Safety of Vatelizumab in Patients Who Completed Treatment in Study DRI13839

NCT02306811

Primary Objective: To assess the long-term safety of vatelizumab in MS patients Secondary Objective: To assess the long-term efficacy of vatelizumab

Relapsing-remitting Multiple Sclerosis

Genzyme, a Sanofi Company62 participantsStarted Feb 2015

Cullman, Alabama, United States • Fort Collins, Colorado, United States • Ormond Beach, Florida, United States +15 more locations

Reliability of Dosing With NovoLog® Mix 70/30 FlexPen® Compared With Vial and Syringe

Efficacy and Safety of Vatelizumab in Patients Who Completed Treatment in Study DRI13839

Multiple Sclerosis Trials in Other Cities

A Multiple Ascending Dose Study of R4733 in Patients With Advanced Solid Tumors.

A Study of RO5045337 [RG7112] in Patients With Advanced Solid Tumors

A Multiple Ascending Dose Study of the mTOR Inhibitor (RAD001) in Combination With R1507 in Patients With Advanced Solid Tumors

JC Virus Antibody Study of Participants With Relapsing Forms of MS Receiving Treatment With Natalizumab

Lapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy.

A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment Into Clinical Research Studies of Zelboraf (Vemurafenib)

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer

A Study of RO5045337 [RG7112] in Patients With Hematologic Neoplasms.

A Multiple Ascending Dose Study of R1530 in Patients With Advanced Solid Tumors.

A Multiple Ascending Dose Study of R1507 in Patients With Advanced Solid Tumors.

A Study of R547 in Patients With Advanced Solid Tumors.

A Study of Vemurafenib (RO5185426) in Participants With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation

Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis

A Pharmacokinetics (PK) Study to Investigate the Effect of Rifampin on PK of Vemurafenib (Zelboraf)

Safety, Tolerability, and Pharmacokinetics of Onartuzumab Combined With Vemurafenib and/or Cobimetinib in Cancer Patients

Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes

Efficacy and Safety of GTR in Comparison to Copaxone®

Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study

Other Conditions in San Antonio